Umeå University's logo

umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
CD46 is a cellular receptor for species D human adenovirus
Umeå University, Faculty of Medicine, Department of Clinical Microbiology.
Umeå University, Faculty of Medicine, Department of Clinical Microbiology.
Umeå University, Faculty of Medicine, Department of Clinical Microbiology.
Institute for Vaccine Research and Development, Hokkaido University, Hokkaido, Japan.
Show others and affiliations
2025 (English)In: mBio, ISSN 2161-2129, E-ISSN 2150-7511, Vol. 16, no 11, article id e0158725Article in journal (Refereed) Published
Abstract [en]

Human adenovirus species D (HAdV-D) contains two-thirds of all known HAdV types (116 in total) and is important as a vector in clinical applications. However, the broad tropism exhibited by several HAdV-D types poses challenges for their use as targeted gene delivery vectors. Since adenoviral tropism is largely governed by receptor usage, we aimed to determine the relative importance of known adenovirus receptors in mediating infection by different HAdV-D types. Here, we generated A549 single-cell CRISPR/Cas9 knockout clones of desmoglein 2 (DSG2), CD46, the coxsackievirus and adenovirus receptor (CAR), and cytidine monophosphate N-acetylneuraminic acid synthetase (CMAS; needed for biosynthesis of sialic acid-containing glycans), and assessed their relative importance for infection by 18 different HAdV-D types. We show that CD46 is the most important receptor for a majority of species D HAdVs. Minor changes in infection levels were noted with A549-ΔCAR and A549-ΔDSG2 cells, whereas A549-ΔCMAS cells displayed an increased susceptibility to infection. We proceed to show that HAdV-D types require CD46 for efficient attachment to A549 cells, and surface plasmon resonance analysis demonstrates that their hexon proteins bind CD46 in an avidity-dependent manner. Strategies to retarget HAdV-D vectors should thus consider hexon-CD46 interactions as a critical determinant of tropism, as CD46 is broadly expressed in vivo. These results increase our understanding of adenovirus-host interactions and will guide the development and targeting of vectors based on HAdV-D types. IMPORTANCE: Several human adenovirus species D (HAdV-D) types are currently used, or under development, as viral vectors for vaccines and gene delivery. However, the unusually broad tropism observed in many HAdV-D types limits their specificity and effectiveness as targeted vectors. Since tropism is largely governed by receptor usage, and previous studies have reported conflicting findings on receptor preferences within this species, clarifying receptor usage is essential. In this study, we systematically investigated receptor usage in 18 different HAdV-D types and identified CD46 as the primary receptor. Since CD46 is widely expressed across human tissues, our findings explain the broad cellular tropism of these viruses and provide valuable insight for the rational design and refinement of HAdV-D-based vectors.

Place, publisher, year, edition, pages
American Society for Microbiology, 2025. Vol. 16, no 11, article id e0158725
Keywords [en]
adenovirus, CD46, receptor-ligand interaction, vector biology, virus-host interactions
National Category
Microbiology in the Medical Area Medical Biotechnology (Focus on Cell Biology, (incl. Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)
Identifiers
URN: urn:nbn:se:umu:diva-246785DOI: 10.1128/mbio.01587-25ISI: 001575516100001PubMedID: 40980888Scopus ID: 2-s2.0-105021474222OAI: oai:DiVA.org:umu-246785DiVA, id: diva2:2016737
Funder
Swedish Research Council, 2023-01831Swedish Research Council, 2019-01472Swedish Cancer Society, 22 2005 PjSwedish Cancer Society, CAN 2018/771EU, Horizon Europe, 101098647Available from: 2025-11-26 Created: 2025-11-26 Last updated: 2025-11-26Bibliographically approved

Open Access in DiVA

fulltext(1039 kB)43 downloads
File information
File name FULLTEXT01.pdfFile size 1039 kBChecksum SHA-512
2cfaf51d7e6fd27396a53f32e1868826337369d11055bfc0aeb0379309a16946207d477045e5a3c399985d378aa9c7173fbc1f88eeb79bbb7423e8e9c10995c4
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Authority records

Danskog, KatarinaFrängsmyr, LarsBecker, MiriamLenman, AnnasaraArnberg, Niklas

Search in DiVA

By author/editor
Danskog, KatarinaFrängsmyr, LarsBecker, MiriamLenman, AnnasaraArnberg, Niklas
By organisation
Department of Clinical MicrobiologyWallenberg Centre for Molecular Medicine at Umeå University (WCMM)Umeå Centre for Microbial Research (UCMR)Molecular Infection Medicine Sweden (MIMS)
In the same journal
mBio
Microbiology in the Medical AreaMedical Biotechnology (Focus on Cell Biology, (incl. Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 486 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf